Precision Business Insights has published a report on the global antibody drug conjugates market, estimating its value at USD 8.49 billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 12.6% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.
View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/antibody-drug-conjugates-market
Antibody Drug Conjugates (ADCs) are targeted cancer medicines that combine monoclonal antibodies with powerful cytotoxic chemicals. The antibody component preferentially attaches to antigens on cancer cells, delivering the cytotoxic payload specifically to the tumour while causing little harm to healthy tissue. When compared to traditional chemotherapy, this precision improves therapeutic effectiveness while reducing systemic toxicity.
Drivers:
- Increasing global cancer incidence is driving demand for more effective and targeted therapies.
- Major pharmaceutical companies are investing heavily in ADC development, with a surge in licensing deals and collaborations.
The global antibody drug conjugates market segmentation:
1) By Drugs: Kadcyla, Adcertis
2) By Mechanism Of Action: CD30 Antibodies, HER2 Antibodies
3) By Application: Breast Cancer, Lymphoma
Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=23717
Regional Overview:
The report also examines the current concerns and their Future Effects on the antibody drug conjugates market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the antibody drug conjugates market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
The competitive landscape is dominated by major players like Roche Holding AG, Pfizer Inc., Bayer HealthCare, Progenics Pharmaceuticals, Roche Holding AG, ImmunoGen, Inc., Celldex Therapeutics, AbbVie Inc., Millennium Pharmaceuticals, Agensys, Inc.
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
